These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15919458)

  • 1. Safety analysis after tacrolimus immunosuppression in renal transplant recipients in Japan: 5-year results in >1500 patients.
    Yoshimura N; Takahara S; Uchida K; Takahashi K; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1764-6. PubMed ID: 15919458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of 3 years of immunosuppression with tacrolimus in more than 1,000 renal transplant recipients in japan.
    Sonoda T; Takahara S; Takahashi K; Uchida K; Ohshima S; Toma H; Tanabe K; Yoshimura N;
    Transplantation; 2003 Jan; 75(2):199-204. PubMed ID: 12548123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of 115 pediatric renal transplant recipients with tacrolimus-based immunosuppressive therapy: a 7-year multicenter study in Japan.
    Hasegawa A; Oshima S; Takahashi K; Uchida K; Ito K; Sonoda T
    Transplant Proc; 2005 May; 37(4):1769-70. PubMed ID: 15919460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful results after 5 years of tacrolimus therapy in ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Takahara S; Uchida K; Yoshimura N; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1800-3. PubMed ID: 15919471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic tacrolimus (Pan Graf) in renal transplantation: an experience of 155 recipients in India.
    Guleria S; Kamboj M; Chatterjee A; Sharma M; Awasthy V; Dinda A; Mahajan S; Bhowmik D; Gupta S; Agarwal SK; Tiwari SC
    Transplant Proc; 2008 Sep; 40(7):2237-9. PubMed ID: 18790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of tacrolimus therapy for renal transplantation in patients with diabetic nephropathy in Japan.
    Sugitani A; Tanaka M; Takahara S; Uchida K; Yoshimura N; Takahashi K; Toma H; Oshima S; Sonoda T;
    Transplant Proc; 2005 May; 37(4):1767-8. PubMed ID: 15919459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary immunosuppression with tacrolimus in renal transplantation: a multicenter, open-label study.
    Mancilla UE; Martinez NB; Alberú J; Diliz H
    Adv Ther; 1999; 16(5):210-8. PubMed ID: 10915396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.
    Bäckman L; Aselius H; Lindberger K; Svensson L; Strömbom U; Olausson E; Hadimeri H; Deurell SI; Norrby J; Gäbel M; Ebermark A; Olausson M
    Transplant Proc; 2006 Oct; 38(8):2654-6. PubMed ID: 17098029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus based immunosuppression.
    First MR
    J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of glucose metabolic abnormalities in Indian living renal allograft recipients on tacrolimus-based triple drug immunosuppression.
    Sharma A; Minz M; Singh S
    Transplant Proc; 2008 Sep; 40(7):2414-5. PubMed ID: 18790252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
    Corman SL; Coley KC; Schonder KS
    Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
    First MR
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi17-vi22. PubMed ID: 15575022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid avoidance immunosuppression in low-risk kidney transplant recipients.
    Heilman RL; Mazur MJ; Reddy KS; Moss A; Post D; Mulligan D
    Transplant Proc; 2005 May; 37(4):1785-8. PubMed ID: 15919466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.